Updates
Disclosure in terms of Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 201131-07-2017
31-07-2017
Updates
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201527-07-2017
Updates
We are pleased to enclose herewith our Press Release relating to announcement of financial results for the first quarter ending June 30, 2017, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you,27-07-2017
Press Release
We are pleased to enclose herewith our Press Release relating to announcement of financial results for the fourth quarter ending March 31, 2017, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you,26-07-2017
Board Meeting On 11/08/2017
Dear Sirs, 1. This is to inform you that a meeting of the Board of Directors of the Company will be held on Friday, August 11, 2017 to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2017. 2. In view of the consideration of above, the window closure for trading by designated persons as per Insider Trading Rules of the Company will be from Wednesday, August 2, 2017 to Wednesday, August 16, 2017 (both days inclusive)....26-07-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia25-07-2017
Shareholding for the Period Ended June 30, 2017
Sun Pharmaceutical Industries Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here18-07-2017
Statement Of Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 30Th June, 2017
As required by Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below Statement of Investor Complaints for the quarter ended 30th June, 2017. Particulars Numbers Pending as on 1st April, 2017 0 Received during the quarter 1 Disposed of during the quarter 1 Unresolved as on 30th June, 2017 017-07-2017
Updates
This is to inform you that pursuant to regulation 30 (5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, pursuant to the Company's policy on determining materiality of events/information, and consequent to the appointment of Mr. Kalyansundaram Subramanian as the Whole-time Director of the Company w.e.f. February 14, 2017 and consequent to the resignation of Mr. Uday Baldota as the...12-07-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Vrundavandas Valia10-07-2017